London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Medical racism could hold back the UK’s Covid-19 vaccination drive

Medical racism could hold back the UK’s Covid-19 vaccination drive

People from BAME communities are more hesitant about getting a coronavirus vaccine – another legacy of the systemic racism in the medical system
After a year of wondering when – or if – it would ever happen, the first people to be vaccinated against Covid-19 in the UK have now received their initial doses. Residents in care homes and their carers are first on the list to receive vaccines, followed by frontline health and social care workers and people aged 80 or over.

By the time healthcare workers get to the bottom of the long list of people who have priority for a Covid-19 vaccine, just under half of the UK population will have received their doses of the vaccine.

But not everyone in the UK will be lining up to get their shot. According to a survey of people in England conducted by the London School of Hygiene & Tropical Medicine and Public Health England, people from BAME backgrounds are almost three times more likely to reject a Covid-19 vaccine than those from white backgrounds.

The same communities that disproportionately felt the worst impacts from Covid-19 are at risk of being left behind again. To reach herd immunity and ensure maximum protection against Covid-19, about 70 per cent of the population will need immunity against the disease, which makes it even more important that no group gets left behind when it comes to vaccines.

There are a number of structural reasons why BAME groups are more likely to encounter the virus. They are more likely to live in densely populated locations and in housing where multiple generations share the same space. To compound the exposure risk, a disproportionate number are employed in public facing roles such as bus and taxi drivers, on the frontline in the NHS and various care home roles.

The structural problems highlighted by the Covid-19 pandemic have not disappeared and could be exacerbated with the roll-out of the vaccine. The events over the summer, particularly the outcry over the killing of George Floyd, the Black Lives Matter movement and even sportspeople taking the knee have created a perception of fundamental societal change. But reversing structural racism cannot be achieved in a few months.

If we are to reach and convince those who are hesitant about a Covid-19 vaccine, we need to understand what is behind their reluctance to get excited by an effective vaccine, even when it is being offered free by the government.

What appears to be scepticism towards taking the new vaccines has some of its roots in structural racism. It is far too simplistic to attribute hesitancy to the influence of the numerous ill informed “anti-vax” campaigns. In a US survey carried out in September, just 32 per cent of Black respondents said they would definitely or probably get a Covid-19 vaccine if it were available at the time – a much lower proportion than white, Hispanic or Asian respondents.

For some, vaccine hesitancy is informed by personal lived experiences leading to a genuine lack of trust in our healthcare systems and providers. In a number of cases what appears to be vaccine hesitancy is actually vaccine ignorance brought about by social exclusion.

People are less likely to hear the public health warnings of the threat from a vaccine-preventable disease if the messages never enter their world. Individuals who do not trust the authorities or who have been denied the education to make an informed choice are equally unlikely to respond to even the best public health messages.

A key government argument for taking the vaccine is that ending the pandemic will return us to the social and economic norms of our pre-pandemic world, this is unlikely to resonate with those who had no stake in the pre-pandemic world and cannot see change coming.

The same structural problems that have made certain groups more likely to be infected and then die from the virus are also likely to prevent effective uptake unless action is taken.

Black people are severely underrepresented in the UK’s database of Covid-19 vaccine clinical trial volunteers, reflecting a similar pattern in the US where Black people are routinely underrepresented even in trials concerning conditions that disproportionately impact Black Americans. Historically vaccine hesitancy is linked to education but in this case it is more about social exclusion and mistrust.

The opportunity to volunteer for any clinical trial is partly through connections, for example being a university student at the type of university where clinical trials are taking place. In many cases volunteering for a clinical trial is well paid, so opportunities may never reach certain excluded communities. Another way to be involved in a trial is to be invited by doctors connected to the trial. Where access to cutting-edge healthcare is limited, such invitations will also be limited.

Although the increased risk from Covid-19 in certain communities is down to social disparities, not genetics, we need clinical trials involving BAME groups to better understand how deprivation, living conditions and comorbidities linked to structural racism will impact on the effectiveness of the vaccine.

Vaccine hesitancy and the lack of BAME people in clinical trials is evidence of social exclusion and structural racism. Unless these underlying factors are changed, the burden of ill health will continue to fall unevenly in our society.

So what can be done? A Public Health England review published in July offers some routes forward. Commissioned after the outcry from Black communities in particular about the disproportionate deaths in the first wave of the pandemic, the report’s chair, Kevin Fenton, made several recommendations around tackling structural racism in medical and public health provision.

Structural problems have meant that too few Black scientists, medical and public health professionals are in positions of influence and power where they can identify problems through research and then communicate solutions.

Such individuals would have greater traction with the hesitant BAME groups. What is worrying is that the government, through the minister for equalities Kemi Badenoch, has been quick to dismiss the role of structural racism in medical outcomes from COVID-19, which is not only wrong but will increase mistrust.
Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×